Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Paul Ausick | May 5, 2014 at 8:00 AM EDT

Pfizer Earnings Confirm Reasons for AstraZeneca Offer

Drug giant Pfizer reported better-than-expected first-quarter 2014 earnings before markets opened Monday morning, but revenues fell short. Shares traded lower…

Paul Ausick | May 2, 2014 at 11:20 AM EDT

Can Endocyte Survive Its Cancer Drug Implosion?

Endocyte and Merck have terminated their joint late-stage study of an ovarian cancer treatment after the trials failed to show…

Paul Ausick | May 2, 2014 at 8:55 AM EDT

AstraZeneca Declares Pfizer Bid ‘Inadequate’

British drug maker AstraZeneca once again rejected a takeover bid from U.S. pharmaceutical giant Pfizer, this one worth $106 billion…

Douglas A. McIntyre | May 2, 2014 at 4:17 AM EDT

Young People Enroll as Obamacare Enrollment Reaches Eight Million

thinkstockObamacare sign ups reached eight million, although the Obama administration put the figure higher because of 4.8 million sign ups…

Jon C. Ogg | May 1, 2014 at 8:45 AM EDT

Why Teva Sees a Sell-the-News Reaction to Decent Earnings

Teva Pharmaceutical is finding a bit of a sell-the-news reaction to its first-quarter earnings report. The company said revenues rose…

Trey Thoelcke | May 1, 2014 at 7:30 AM EDT

Mylan Falls Short on Revenues, Hints at Acquisition to Come

Mylan reported first-quarter 2014 results before markets opened Thursday. The generic drug maker reaffirmed its full-year EPS guidance and hinted…

Douglas A. McIntyre | May 1, 2014 at 6:35 AM EDT

States Where People Go to the Dentist

ThinkstockClean teeth are supposed to be good for heart health, and a way to avoid dentures and to avoid the…

Jon C. Ogg | Apr 30, 2014 at 3:52 PM EDT

Salvation for Avanir in Patent Exclusivity

ThinkstockAvanir Pharmaceuticals, Inc. (NASDAQ: AVNR) is seeing a late day surge on Wednesday after news broke that the company has…

Trey Thoelcke | Apr 29, 2014 at 9:25 AM EDT

Five Top Health Care Names From RBC to Buy Now

ThinkstockThe intense analysis of quantitative managers may seem like drudgery, but it can turn up absolute gems for investors looking…

Paul Ausick | Apr 29, 2014 at 7:45 AM EDT

Merck Earnings Mixed as Drug Sales Slow

Merck & Co. reported mixed first-quarter 2014 results before markets opened Tuesday morning. The loss of market exclusivity continues to…

Thomas Frohlich | Apr 29, 2014 at 7:43 AM EDT

America’s Most (and Least) Healthy Cities

ThinkstockThere’s no doubt that great strides have been made in Americans’ health over the years. Americans smoke less, are more…

Trey Thoelcke | Apr 28, 2014 at 10:35 AM EDT

Meda Shareholder Blocks Mylan’s Second Takeover Bid

Shares of Mylan retreated first thing Monday morning, after the generic drugmaker's sweetened bid for Swedish drugmaker Meda was rejected.

cgblaine22 | Apr 26, 2014 at 8:30 AM EDT

Biotech: The Poster Child for Market Volatility in 2014

The NYSE Arca Biotechnology Index fell nearly 9% between a peak on Jan. 22 and a low on Feb. 5.…

Trey Thoelcke | Apr 24, 2014 at 7:00 AM EDT

Expired Patents Take a Bite out of Eli Lilly Results

Eli Lilly reported disappointing first-quarter 2014 results before markets opened Thursday, due in part to the impact of U.S. patent…

Jon C. Ogg | Apr 23, 2014 at 3:35 PM EDT

Why Investors Are Not Chasing Gilead Endlessly Higher

ThinkstockBy any stretch of normal measurement in earnings season, Gilead Sciences Inc. (NASDAQ: GILD) should have been a rocketing stock…

1 … 287 288 289 290 291 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Pfizer Earnings Confirm Reasons for AstraZeneca Offer

Can Endocyte Survive Its Cancer Drug Implosion?

AstraZeneca Declares Pfizer Bid ‘Inadequate’

Young People Enroll as Obamacare Enrollment Reaches Eight Million

Why Teva Sees a Sell-the-News Reaction to Decent Earnings

Mylan Falls Short on Revenues, Hints at Acquisition to Come

States Where People Go to the Dentist

Salvation for Avanir in Patent Exclusivity

Five Top Health Care Names From RBC to Buy Now

Merck Earnings Mixed as Drug Sales Slow

America’s Most (and Least) Healthy Cities

Meda Shareholder Blocks Mylan’s Second Takeover Bid

Biotech: The Poster Child for Market Volatility in 2014

Expired Patents Take a Bite out of Eli Lilly Results

Why Investors Are Not Chasing Gilead Endlessly Higher

Bitcoin Price Hits $80K: We Asked Grok If BTC Could Hold $80K in May

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

Bitcoin Price Hits $80K: We Asked Grok If BTC Could Hold $80K in May

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

Health and Healthcare Articles

All Health and Healthcare Articles

Pfizer Earnings Confirm Reasons for AstraZeneca Offer

Can Endocyte Survive Its Cancer Drug Implosion?

AstraZeneca Declares Pfizer Bid ‘Inadequate’

Young People Enroll as Obamacare Enrollment Reaches Eight Million

Why Teva Sees a Sell-the-News Reaction to Decent Earnings

Mylan Falls Short on Revenues, Hints at Acquisition to Come

States Where People Go to the Dentist

Salvation for Avanir in Patent Exclusivity

Five Top Health Care Names From RBC to Buy Now

Merck Earnings Mixed as Drug Sales Slow

America’s Most (and Least) Healthy Cities

Meda Shareholder Blocks Mylan’s Second Takeover Bid

Biotech: The Poster Child for Market Volatility in 2014

Expired Patents Take a Bite out of Eli Lilly Results

Why Investors Are Not Chasing Gilead Endlessly Higher

Bitcoin Price Hits $80K: We Asked Grok If BTC Could Hold $80K in May

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up